Cargando…

METTL3 Is Associated With the Malignancy of Esophageal Squamous Cell Carcinoma and Serves as a Potential Immunotherapy Biomarker

Methyltransferase-like 3 (METTL3) is an RNA methyltransferase mediating N6 methyladenosine (m6A) modification. Its role in cancer pathogenesis and progression has attracted increasing attention. However, the immunological role, possible immune mechanism, and clinical significance of METTL3 in esopha...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Yubin, Guo, Songhe, Li, Yiqiu, Chen, Fangfang, Wu, Yaxian, Xiao, Yi, An, Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9094700/ https://www.ncbi.nlm.nih.gov/pubmed/35574315 http://dx.doi.org/10.3389/fonc.2022.824190

Ejemplares similares

Inflammation-related parameter serve as prognostic biomarker in esophageal squamous cell carcinoma
por: Xu, Xiaoqin, et al.
Publicado: (2022)

DDX60 Is Associated With Glioma Malignancy and Serves as a Potential Immunotherapy Biomarker
por: Zhang, Jingwen, et al.
Publicado: (2021)

METTL3 Promotes Esophageal Squamous Cell Carcinoma Metastasis Through Enhancing GLS2 Expression
por: Chen, Xiaoting, et al.
Publicado: (2021)

N6-Methyladenosine Methyltransferase METTL14-Mediated Autophagy in Malignant Development of Oral Squamous Cell Carcinoma
por: Wang, Fang, et al.
Publicado: (2021)

ZCCHC17 Served as a Predictive Biomarker for Prognosis and Immunotherapy in Hepatocellular Carcinoma
por: Liu, Fahui, et al.
Publicado: (2022)

Identification METTL18 as a Potential Prognosis Biomarker and Associated With Immune Infiltrates in Hepatocellular Carcinoma
por: Li, Tian-Hao, et al.
Publicado: (2021)

IL6 and BCL3 Expression Are Potential Biomarkers in Esophageal Squamous Cell Carcinoma
por: Soares-Lima, Sheila Coelho, et al.
Publicado: (2021)

Identification of prognostic biomarkers in papillary renal cell carcinoma and PTTG1 may serve as a biomarker for predicting immunotherapy response
por: Tian, Xi, et al.
Publicado: (2022)

METTL3/m(6)A/IFIT2 regulates proliferation, invasion and immunity in esophageal squamous cell carcinoma
por: Ge, Fangfang, et al.
Publicado: (2022)

Biomarkers for Immunotherapy of Oral Squamous Cell Carcinoma: Current Status and Challenges
por: Almangush, Alhadi, et al.
Publicado: (2021)

The Role of RNA Methyltransferase METTL3 in Normal and Malignant Hematopoiesis
por: Wu, Xia, et al.
Publicado: (2022)

An Update on the Immunotherapy for Oropharyngeal Squamous Cell Carcinoma
por: Huang, Yaxuan, et al.
Publicado: (2022)

Oncogenic KPNA2 Serves as a Biomarker and Immune Infiltration in Patients With HPV Positive Tongue Squamous Cell Carcinoma
por: Gao, Li, et al.
Publicado: (2022)

Transgelin Inhibits the Malignant Progression of Esophageal Squamous Cell Carcinomas by Regulating Epithelial–Mesenchymal Transition
por: Yang, Boli, et al.
Publicado: (2021)

Plasma Metabolomics Reveals Diagnostic Biomarkers and Risk Factors for Esophageal Squamous Cell Carcinoma
por: Yu, Mengjie, et al.
Publicado: (2022)

METTL5 serves as a diagnostic and prognostic biomarker in hepatocellular carcinoma by influencing the immune microenvironment
por: Wang, Lei, et al.
Publicado: (2023)

The prognosis value of CONUT and SIS score for recurrent or metastatic esophageal squamous cell carcinoma patients treated with second-line immunotherapy
por: Zhao, Xiao-Han, et al.
Publicado: (2023)

Genomic Variations in Esophageal Squamous Cell Carcinoma and Esophageal Adenocarcinoma
por: Yasar, Hatime A
Publicado: (2023)

Identification of a seven-lncRNAs panel that serves as a prognosis predictor and contributes to the malignant progression of laryngeal squamous cell carcinoma
por: Zheng, Xiwang, et al.
Publicado: (2023)

Corrigendum: Transgelin Inhibits the Malignant Progression of Esophageal Squamous Cell Carcinomas by Regulating Epithelial–Mesenchymal Transition
por: Yang, Boli, et al.
Publicado: (2022)

Postoperative serum squamous cell carcinoma antigen and carcinoembryonic antigen predict overall survival in surgical patients with esophageal squamous cell carcinoma
por: Huang, Yi, et al.
Publicado: (2023)

Serum Metabolomic Profiling Reveals Biomarkers for Early Detection and Prognosis of Esophageal Squamous Cell Carcinoma
por: Wang, Pan Pan, et al.
Publicado: (2022)

Immunotherapy for the Treatment of Cutaneous Squamous Cell Carcinoma
por: Boutros, Andrea, et al.
Publicado: (2021)

Exosomal Cripto-1 Serves as a Potential Biomarker for Perihilar Cholangiocarcinoma
por: Hu, Chunxiao, et al.
Publicado: (2021)

A four-microRNA panel in serum may serve as potential biomarker for renal cell carcinoma diagnosis
por: Li, Rongkang, et al.
Publicado: (2023)

Identification of Immune-Cell-Related Prognostic Biomarkers of Esophageal Squamous Cell Carcinoma Based on Tumor Microenvironment
por: Cui, Yiyao, et al.
Publicado: (2021)

Immunotherapy for Esophageal Squamous Cell Carcinoma
por: Kojima, Takashi, et al.
Publicado: (2017)

SRSF3 Expression Serves as a Potential Biomarker for Prognostic and Immune Response in Pan-Cancer
por: Li, Zihua, et al.
Publicado: (2022)

Interferon-Induced Protein 44 Correlated With Immune Infiltration Serves as a Potential Prognostic Indicator in Head and Neck Squamous Cell Carcinoma
por: Pan, Hua, et al.
Publicado: (2020)

The Tumor Microenvironment and Immunotherapy of Oropharyngeal Squamous Cell Carcinoma
por: Welters, Marij J. P., et al.
Publicado: (2020)

Immunotherapy for Cutaneous Squamous Cell Carcinoma: Results and Perspectives
por: Alberti, Andrea, et al.
Publicado: (2022)

Identification and Evaluation of Autoantibody to a Novel Tumor-Associated Antigen GNA11 as a Biomarker in Esophageal Squamous Cell Carcinoma
por: Wang, Huimin, et al.
Publicado: (2021)

Upregulation of METTL3 Expression Predicts Poor Prognosis in Patients with Esophageal Squamous Cell Carcinoma
por: Xia, Tian-Liang, et al.
Publicado: (2020)

Identification of Serum MicroRNAs as Novel Biomarkers in Esophageal Squamous Cell Carcinoma Using Feature Selection Algorithms
por: Zheng, Deqiang, et al.
Publicado: (2019)

Wnt signaling pathway-related gene PRICKLE1 is a prognostic biomarker for esophageal squamous cell carcinoma
por: He, Jinxian, et al.
Publicado: (2023)

Five-lncRNA signature in plasma exosomes serves as diagnostic biomarker for esophageal squamous cell carcinoma
por: Jiao, Zichen, et al.
Publicado: (2020)

Prognostic Value of Lactate Dehydrogenase in Second-Line Immunotherapy for Advanced Esophageal Squamous Cell Carcinoma
por: Li, Yan, et al.
Publicado: (2022)

CCNF is a potential pancancer biomarker and immunotherapy target
por: Wei, Lifang, et al.
Publicado: (2023)

Mutational Landscape of Esophageal Squamous Cell Carcinoma in an Indian Cohort
por: Mangalaparthi, Kiran K., et al.
Publicado: (2020)

Extensive Presentation of Penile Carcinoma Cuniculatum a Variant of Squamous Cell Carcinoma With Low Malignant Potential
por: Vinson, Mohabe A., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_s8cucnsio3c1a3i5nc8d3ldupg